Illumina
ILMN • NASDAQ
Illumina is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Jacob Thaysen, with a market cap of $18.0B.
CEOJacob Thaysen
Next Earnings
Upcoming earnings announcement for Illumina
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$1.06
Revenue Estimate
$1.1B
Earnings History
Past 12 earnings reports for Illumina
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 5, 2026 | Q4 2025 | $1.35Est: $1.25 | +8.0% | $1.2BEst: $1.1B | +2.6% | — |
| Oct 30, 2025 | Q3 2025 | $1.34Est: $1.16 | +15.5% | $1.1BEst: $1.1B | +1.6% |  10-Q |
| Jul 31, 2025 | Q2 2025 | $1.19Est: $1.01 | +17.8% | $1.1BEst: $1.1B | +0.7% | 10-Q |
| May 8, 2025 | Q1 2025 | $0.97Est: $0.94 | +3.2% | $1.0BEst: $1.0B | +0.1% | 10-Q |
| Feb 6, 2025 | Q4 2024 | $0.95Est: $0.92 | +3.3% | $1.1BEst: $1.1B | +0.4% | 10-K |
| Nov 4, 2024 | Q3 2024 | $1.14Est: $0.88 | +29.5% | $1.1BEst: $1.1B | 0.0% | 10-Q |
| Aug 6, 2024 | Q2 2024 | $0.36Est: $0.90 | -60.0% | $1.1BEst: $1.1B | +3.0% | 10-Q |
| May 2, 2024 | Q1 2024 | $0.09Est: $0.04 | +125.0% | $1.1BEst: $1.1B | +2.5% | 10-Q |
| Feb 8, 2024 | Q4 2023 | $0.14Est: $0.02 | +600.0% | $1.1BEst: $1.1B | +2.9% | 10-K |
| Nov 9, 2023 | Q3 2023 | $0.33Est: $0.12 | +175.0% | $1.1BEst: $1.1B | -1.0% | — |
| Aug 9, 2023 | Q2 2023 | $0.32Est: $0.02 | +1500.0% | $1.2BEst: $1.2B | +1.4% | 10-Q |
| Apr 25, 2023 | Q1 2023 | $0.08Est: $0.02 | +300.0% | $1.1BEst: $1.1B | +1.6% | 10-Q |